Viewing Study NCT03942094


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-03-06 @ 3:01 AM
Study NCT ID: NCT03942094
Status: UNKNOWN
Last Update Posted: 2022-03-16
First Post: 2019-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nilotinib for First-line Newly Diagnosed CML-CP Patients
Sponsor: Shenzhen Second People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module